No Evidence for Genetically Determined Alteration in Insulin Secretion or Sensitivity Predisposing to Type 1 Diabetes
A study of identical twins
- Mohammed I. Hawa, BSC,
- Riccardo Bonfanti, MD,
- Christina Valeri, MD,
- Michela Delli Castelli, MD,
- Huriya Beyan, PHD and
- R. David G. Leslie, MD
- From the Department of Diabetes and Metabolism, St. Bartholomew’s Hospital, Institute of Cell and Molecular Science, London, U.K.
- Address correspondence and reprint requests to Prof. David Leslie, St. Bartholomew’s Hospital, West Smithfield, London EC1A 7BE, U.K. E-mail: r.d.g.leslie{at}qmul.ac.uk
Abstract
OBJECTIVE— To determine whether inherited changes in insulin secretion or sensitivity could predispose to type 1 diabetes, we studied identical twins of type 1 diabetic patients.
RESEARCH DESIGN AND METHODS— We studied prospectively a consecutive series of 27 identical twins of patients with type 1 diabetes who were initially nondiabetic, as well as 14 control subjects, over a period of 18 years. Of these 27 twins, 15 remain nondiabetic (now estimated at low disease risk) and 12 developed diabetes (pre-diabetic twins). Subjects were tested when not diabetic on at least two occasions with an intravenous glucose tolerance test (IVGTT), and we estimated insulin secretion as first-phase insulin response (FPIR), glucose clearance (Kg), and insulin sensitivity both by homeostasis model assessment of insulin resistance (HOMA-IR) and relative to insulin response by the basal HOMA-IR–to–FPIR ratio.
RESULTS— Twins now at low risk and control subjects had similar fasting blood glucose and insulin levels, FPIR, Kg, HOMA-IR, and HOMA-IR–to–FPIR ratio. In contrast, pre-diabetic twins compared with control twins had higher fasting insulin levels (10.3 ± 6.0 vs. 4.6 ± 4.0 mIU/ml), lower FPIR (245 ± 129 vs. 796 ± 622 mIU · ml−1 · 10 min−1), lower Kg (1.5 ± 0.6 vs. 2.6 ± 0.8% per min), and higher HOMA-IR–to–FPIR ratio (0.007 ± 0.005 vs. 0.001 ± 0.0009) (all P < 0.01).
CONCLUSIONS— These observations in low-risk nondiabetic identical twins failed to identify a familial alteration in either insulin secretion or sensitivity predisposing to type 1 diabetes.
- FPIR, first-phase insulin response
- HOMA-IR, homeostasis model assessment of insulin resistance
- IA-2, insulinoma-associated protein 2
- IVGTT, intravenous glucose tolerance test
Footnotes
-
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
-
- Accepted February 24, 2005.
- Received October 21, 2004.
- DIABETES CARE














